Currently, there are 90.47M common shares owned by the public and among those 85.13M shares have been available to trade.
The company’s stock has a 5-day price change of -1.55% and 3.53% over the past three months. LAZ shares are trading 49.20% year to date (YTD), with the 12-month market performance up to 50.23% higher. It has a 12-month low price of $34.25 and touched a high of $61.14 over the same period. LAZ has an average intraday trading volume of 781.47K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.52%, -4.61%, and 13.45% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Lazard Inc (NYSE: LAZ) shares accounts for 91.23% of the company’s 90.47M shares outstanding.
It has a market capitalization of $4.70B and a beta (3y monthly) value of 1.38. The stock’s trailing 12-month PE ratio is 20.65, while the earnings-per-share (ttm) stands at $2.51. The company has a PEG of 10.33 and the debt-to-equity ratio at 3.80. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.30% over the week and 3.16% over the month.
Earnings per share for the fiscal year are expected to increase by 182.22%, and 83.29% over the next financial year.
Looking at the support for the LAZ, a number of firms have released research notes about the stock. Keefe Bruyette stated their Mkt Perform rating for the stock in a research note on December 20, 2024, with the firm’s price target at $65-$57. Morgan Stanley coverage for the Lazard Inc (LAZ) stock in a research note released on December 09, 2024 offered a Equal-Weight rating with a price target of $63. Wells Fargo was of a view on September 12, 2024 that the stock is Equal Weight, while Keefe Bruyette gave the stock Outperform rating on January 29, 2024, issuing a price target of $51. Wolfe Research on their part issued Outperform rating on January 03, 2024.
